Effectiveness and Safety of DLBS3233 in Newly Diagnosed Type 2 Diabetes Mellitus: A 12-week Clinical Trial
Background: DLBS3233, recognized as an agent enhancing insulin sensitivity, has exhibited promise as a therapeutic option for addressing type 2 diabetes mellitus (T2DM). This study aimed to evaluate the effectiveness and safety of DLBS3233, a natural compound, in individuals newly diagnosed with T2...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Interna Publishing
2024-10-01
|
| Серія: | Acta Medica Indonesiana |
| Предмети: | |
| Онлайн доступ: | http://www.actamedindones.org/index.php/ijim/article/view/2621 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|